Back to results
US 2005/0033043 A1Published application
Process for preparing purine nucleosides
AssigneeGenzyme Corporation
InventorsWilliam Bauta, Brian Burke, Brian Schulmeier, William Cantrell, Dennis Lovett, Jose Puente
Life of this patent
Estimating the term…
Abstract
The present invention for the stereoselective preparation of 2-deoxy-β-D-adenine nucleosides wherein a blocked 2-deoxy-α-D-arabinofuranosyl halide is coupled with the salt of an adenine derivative.
Claims30
A process for the stereoselective preparation of a 2′-deoxy-β-nucleoside of the formula:
- wherein, R2 and R3 are independently hydroxy protecting groups, R7 and R8 are independently hydrogen, C1-C4 alkyl, or amino protecting groups, and R11 is a halogen or —NR6R7, wherein R6 and R7 are as described above, comprising reacting a 2-deoxy-α-arabinofuranosyl derivative of the formula:
- wherein R9 is a halogen and R2 and R3 are as defined above, with an adenine derivative potassium salt of the formula:
- wherein R7, R8 and R11 are as defined above in the presence of a substantially anhydrous solvent, and wherein said 2′-deoxy-β-nucleoside is produced in said substantially anhydrous solvent in a molar ratio of greater than 10:1 relative to the 2′-deoxy-α-nucleoside anomer represented by the formula:
A process for the stereoselective preparation of a 2′-deoxy-β-nucleoside of the formula:
- wherein, R2 and R3 are independently hydroxy protecting groups, comprising reacting a 2-deoxy-α-arabinofuranosyl derivative of the formula:
- wherein R2 and R3 are as defined above, with 2-chloroadenine, in the presence of a substantially anhydrous solvent, and a hindered potassium base with a pKa in water of 15 or above, and wherein said 2′-deoxy-β-nucleoside is produced in a molar ratio of greater then 10:1 relative to the 2′-deoxy-α-nucleoside anomer represented by the formula:
Dependencies are inferred from the claim text.